How cannabis works in the brain

doi:10.1017/CBO9780511543630.004

2 - How cannabis works in the brain

Published online by Cambridge University Press: 07 December 2009

Leslie Iversen

Edited by

David Castle and

Robin Murray

Show author details

Leslie Iversen: Affiliation:
University of Oxford, UK
David Castle: Affiliation:
Mental Health Research Institute, Melbourne
Robin Murray: Affiliation:
Institute of Psychiatry, London

Book contents

Get access

Summary

Important advances have been made in the past decade in understanding how cannabis affects the brain. As with morphine 20 years earlier, research on the psychopharmacology of a plant-derived drug led to the discovery of a naturally occurring cannabinoid system in the brain, whose functions are only now beginning to be understood. This chapter will review what is known about the interactions of cannabis with the cannabinoid system in the brain and how the drug affects psychomotor, cognitive, perceptual and appetitive functions. There is also speculation on what brain mechanisms may underly the intoxicant effects of cannabis, and a review of its addictive properties.

Cannabinoid receptors

In Chapter 1 the identification of Δ9-tetrahydrocannabinol (THC) was reviewed as the principal active component in the complex mixture of cannabinoids present in extracts of the plant Cannabis sativa, and the discovery of a series of naturally occurring endogenous cannabinoids (endocannabinoids), of which anandamide has so far been most intensively studied, was outlined. A series of synthetic cannabinoids – some of which are more potent and more water-soluble than THC – is also available (Pertwee, 1999) (Fig. 2.1). All of these compounds act as agonists at the CB1 cannabinoid receptor (Matsuda et al., 1990), which is the only one known to be expressed in the brain. A second cannabinoid receptor, CB2, is expressed only in peripheral tissues, principally in the immune system (Munro et al., 1993; Felder and Glass, 1998; Pertwee, 1999).

Type: Chapter
Information: Marijuana and Madness
Psychiatry and Neurobiology
, pp. 19 - 40

DOI: https://doi.org/10.1017/CBO9780511543630.004 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Abel, E. L. (1971). Marihuana and memory: acquisition or retrieval?Science, 173, 1038–1041CrossRef Google Scholar PubMed

Aceto, M. D., Scates, S. M., Lowe, J. A. and Martin, B. R (1996). Dependence on Δ9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal. J. Pharmacol. Exp. Ther., 278, 1290–1295Google Scholar PubMed

Aceto, M. D., Scates, S. M. and Martin, B. R. (2001). Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212–2. Eur. J. Pharmacol., 416, 75–81CrossRef Google Scholar PubMed

Adams, I. B. and Martin, B. R. (1996). Cannabis: pharmacology and toxicology in animals and humans. Addiction, 91, 1585–1614CrossRef Google Scholar PubMed

Alger, B. E. and Pitler, T. A. (1995). Retrograde signaling at GABAA-receptor synapses in the mammalian CNS. Trends Neurosci., 18, 333–340CrossRef Google Scholar PubMed

American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, DC: American Psychiatric Association

Anthony, J. C., Warner, L. A. and Kessler, R. C. (1994). Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants. Basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol., 2, 244–268CrossRef Google Scholar

Atha, M. J. and Blanchard, S. (1997). Self Reported Consumption Patterns and Attitudes Towards Drugs Among 1333 Regular Cannabis Users. Wigan, UK: Independent Drug Monitoring Unit

Beal, J. A., Olson, R., Laubenstein, L.et al. (1995). Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J. Pain Symptom Manage., 10, 89–97CrossRef Google Scholar PubMed

Bohme, G. A., Laville, M., Ledent, C., Paramentier, M. and Imperato, A. (2000). Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience, 95, 5–7CrossRef Google Scholar PubMed

Breivogel, C. S. and Childers, S. R. (1998). The functional neuroanatomy of brain cannabinoid receptors. Neurobiol. Dis., 5, 417–431CrossRef Google Scholar PubMed

Brett, R., MacKenzie, F. and Pratt, J. (2001). Delta-9-tetrahydrocannabinol-induced alterations in limbic system glucose use in the rat. Neuro-Report, 12, 3573–3577Google Scholar PubMed

Budney, A. J., Hughes, J. R., Moore, B. A. and Novy, P. L. (2001). Marijuana abstinence effects in marijuana smokers maintained in their home environment. Arch. Gen. Psychiatry, 58, 917–924CrossRef Google Scholar PubMed

Cadoni, C., Pisanu, A., Solinas, M., Acquas, E. and Di Chiara, G. (2001). Behavioural sensitization after repeated exposure to delta-9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology, 158, 259–266CrossRef Google Scholar PubMed

Colombo, G., Agabio, R., Diaz, G.et al. (1998). Appetite suppression and weight loss after the cannabinoid antagonist SR141716A. Life Sci., 63, PL113–PL117CrossRef Google Scholar

Compton, D. R., Aceto, M. D., Lowe, J. and Martin, B. R. (1996). In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A) inhibition of Δ9-tetrahydocannabinol-induced responses and apparent agonist activity. J. Pharmacol. Exp. Ther., 277, 586–594Google Scholar PubMed

Deadwyler, S. A., Hampson, R. E. and Childers, S. R. (1995). Functional significance of cannabinoid receptors in brain. In Cannabinoid Receptors, ed. R. G. Pertwee, pp. 206–231. London: Academic Press

DeSanty, K. P. and Dar, M. S. (2001). Cannabinoid-induced motor incoordination through the cerebellar CB1 receptor in mice. Pharmacol. Biochem. Behav., 69, 251–259CrossRef Google Scholar

Diana, M., Melis, M., Muntoni, A. L. and Gessa, G. L. (1998). Mesolimbic dopaminergic decline after cannabinoid withdrawal. Proc. Natl Acad. Sci. USA, 95, 10269–10273CrossRef Google Scholar PubMed

Dixon, W. E. (1899). The pharmacology of cannabis indica. Br. Med. J. 11, 1354–1357Google Scholar

D'Souza, D. C. and Kosten, T. R. (2001). Cannabinoid antagonists. Arch. Gen. Psychiatry, 58, 330–331CrossRef Google Scholar PubMed

Earlywine, M. (2002). Understanding Marijuana. New York: Oxford University Press

Egertová, M. and Elphick, M. R. (2000). Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1. J. Comp. Neurol., 422, 159–1713.0.CO;2-1>CrossRef Google Scholar

Egertová, M., Giang, D. K., Cravatt, B. F. and Elphick, M. R. (1998). A new perspective on cannabinoid signaling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in the rat brain. Proc. R. Soc. Lond. B, 265, 2081–2085CrossRef Google Scholar PubMed

Elphick, M. R. and Egertová, M. (2001). The neurobiology and evolution of cannabinoid signaling. Phil. Trans. R. Soc. Lond., 356, 381–408CrossRef Google Scholar

Felder, C. C. and Glass, M. (1998). Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol., 38, 179–200CrossRef Google Scholar PubMed

Freedland, C. S., Whitlow, C. T., Miller, M. D. and Porrino, L. J. (2002). Dose-dependent effects of delta-9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat. Synapse, 45, 134–142CrossRef Google Scholar PubMed

French, E. D., Dillon, K. and Wu, X. (1997). Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. NeuroReport, 8, 649–652CrossRef Google Scholar PubMed

Fride, E., Ginzburg, Y., Breuer, A.et al. (2001). Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Eur. J. Pharmacol., 419, 207–214CrossRef Google Scholar

Fuentes, J. A., Ruiz-Gayo, M., Manzanares, J.et al. (1999). Cannabinoids as potential new analgesics. Life Sci., 65, 675–685CrossRef Google Scholar PubMed

Gerdeman, G. L., Ronesi, J. and Lovinger, D. M. (2002). Postsynaptic endocannabinoid release is critical to long-term depression in the striatum. Nature Neurosci., 5, 446–451CrossRef Google Scholar PubMed

Ghozland, S., Matthes, H. W., Simonin, F.et al. (2002). Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J. Neurosci., 22, 1146–1154CrossRef Google Scholar PubMed

Gill, E. W., Paton, W. D. M. and Pertwee, R. G. (1970). Preliminary experiments on the chemistry and pharmacology of cannabis. Nature, 229, 134–136CrossRef Google Scholar

Giuffrida, A. and Piomelli, D. (2000). The endocannabinoid system: a physiological perspective on its role in psychomotor control. Chem. Physics Lipids, 108, 151–158CrossRef Google Scholar PubMed

Giuffrida, A., Parsons, L. H., Kerr, T. M.et al. (1999). Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nature Neurosci., 2, 358–363CrossRef Google Scholar PubMed

Greenberg, H. S., Werness, S. A. S., Pugh, J. E.et al. (1994). Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers. Clin. Pharmacol. Ther., 55, 324–328CrossRef Google Scholar PubMed

Hájos, N., Katona, I., Naiem, S. S.et al. (2000). Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci., 12, 3239–3249CrossRef Google Scholar PubMed

Hampson, R. E. and Deadwyler, S. A. (1999). Cannabinoids, hippocampal function and memory. Life Sci., 65, 715–723CrossRef Google Scholar PubMed

Han, C. J. and Robinson, J. K. (2001). Cannabinoid modulation of time estimation in the rat. Behav. Neurosci., 115, 243–246CrossRef Google Scholar PubMed

Herkenham, M., Lynn, A. B., Johnson, M. R.et al. (1991). Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563–583CrossRef Google Scholar PubMed

Hicks, R. E., Gualtieri, C. T., Mayo, P. Jr and Perez-Reyes, M. (1984). Cannabis, atropine and temporal information processing. Neuropsychobiology, 12, 229–237CrossRef Google Scholar PubMed

Hine, B., Friedman, E., Torrelio, M. and Gershon, S. (1975). Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol. Science, 187, 443–445CrossRef Google Scholar PubMed

Hoffman, A. F. and Lupica, C. R. (2000). Mechanisms of cannabinoid inhibition of GABAA synaptic transmission in the hippocampus. J. Neurosci., 20, 2470–2479CrossRef Google Scholar

Hollister, L. E. (1971). Hunger and appetite after single doses of marihuana, alcohol and dextroamphetamine. Clin. Pharmacol. Ther., 12, 44–49CrossRef Google Scholar PubMed

Hollister, L. E. (1986). Health aspects of cannabis. Pharmacol. Rev., 38, 1–20Google Scholar PubMed

Hollister, L. E. (1998). Health aspects of cannabis: revisited. Int. J. Neuropsychopharmacol., 1, 71–80CrossRef Google Scholar PubMed

Huestis, M. A., Gorelick, D. A., Heishman, S. J.et al. (2001). Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry, 58, 322–328CrossRef Google Scholar PubMed

Iversen, L. L. (2000). The Science of Marijuana. New York: Oxford University Press

Jones, R. T. (1978). Marihuana: human effects. In Handbook of Psychopharmacology, vol. 12, ed. L. L. Iversen, S. D. Iversen and S. H. Snyder, pp. 373–412. New York: Plenum PressCrossRef

Jones, R. T. (1987). Drug of abuse profile: cannabis. Clin. Chem., 33, 72B–81BGoogle Scholar PubMed

Katona, I., Sperlagh, B., Sik, A.et al. (1999). Presynaptically located CB1 receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci., 19, 4544–4558CrossRef Google Scholar PubMed

Katona, I., Sperlagh, B., Maglóczky, Z.et al. (2000). GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience, 100, 797–804CrossRef Google Scholar PubMed

Katona, I., Rancz, E. A., Acsády, L.et al. (2001). Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J. Neurosci., 21, 9506–9518CrossRef Google Scholar PubMed

Kaymakçalan, S., Ayhan, I. H. and Tulunay, F. C. (1977). Naloxone-induced or postwithdrawal abstinence signs in Δ9-tetrahydrocannabinol-tolerant rats. Psychopharmacology, 55, 243–249CrossRef Google Scholar PubMed

Koch, J. E. (2001). Δ9-THC stimulates food intake in Lewis rats. Effects on chow, high-fat and sweet high-fat diets. Pharmacol. Biochem. Behav., 68, 539–543CrossRef Google Scholar PubMed

Kreitzer, A. C. and Regehr, W. G. (2001a). Retrograde ion of prinhibitesynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron, 29, 717–727CrossRef Google Scholar

Kreitzer, A. C. (2001b). Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J. Neurosci., 21, RC174–RC179CrossRef Google Scholar

Ledent, C., Valverde, O., Cossu, G.et al. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science, 283, 401–404CrossRef Google Scholar PubMed

Lenz, R. A., Wagner, J. J. and Alger, B. E. (1998). N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J. Physiol. (Lond.), 512, 61–73CrossRef Google Scholar PubMed

Lepore, M., Vorel, S. R., Lowinson, J. and Gardner, E. L. (1995). Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine and food reward. Life Sci., 56, 2073–2080CrossRef Google Scholar PubMed

Lichtman, A. H. and Martin, B. R. (1996). Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid mechanism. Psychopharmacology, 126, 125–131CrossRef Google Scholar

Lichtman, A. H., Fisher, J. and Martin, B. R. (2001a). Precipitated cannabinoid withdrawal is reversed by Δ9-tetrahydrocannabinol or clonidine. Pharmacol. Biochem. Behav., 69, 181–188CrossRef Google Scholar

Lichtman, A. H., Sheikh, S. M., Loh, H. H. and Martin, B. R. (2001b). Opioid and cannabinoid modulation of precipitated withdrawal in Δ9-tetrahydrocannabinol and morphine-dependent mice. J. Pharmacol. Exp. Ther., 298, 1007–1014Google Scholar

Maejima, T., Hashimoto, K., Yoshida, T., Aiba, A. and Kano, M. (2001). Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron, 31, 463–475CrossRef Google Scholar PubMed

Mallet, P. E. and Beninger, R. J. (1998). The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by Δ9-tetrahydrocannabinol or anandamide. Psychopharmacology, 140, 11–19CrossRef Google Scholar PubMed

Manno, J. E., Glenn, M. S., Kiplinger, G. F.et al. (1970). Comparative effects of smoking marihuana or placebo on human motor and mental performance. Clin. Pharmacol. Ther., 11, 808–815CrossRef Google Scholar PubMed

Marsicano, G. and Lutz, B. (1999). Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci., 11, 4213–4225CrossRef Google Scholar PubMed

Marsicano, G., Wotjak, C. T., Azad, S. C.et al. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418, 530–534CrossRef Google Scholar PubMed

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C. and Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561–564CrossRef Google Scholar PubMed

Mattes, R. D., Engelman, K., Shaw, L. M. and Elsohly, M. A. (1994). Cannabinoids and appetite stimulation. Pharmacol. Biochem. Behav., 49, 187–194CrossRef Google Scholar PubMed

Mathew, R. J., Wilson, W. H., Coleman, R. E., Turkington, T. G. and DeGrado, T. R. (1997). Marijuana intoxication and brain activation in marijuana smokers. Life Sci., 60, 2075–2089CrossRef Google Scholar PubMed

Mathew, R. J., Wilson, W. H., Turkington, T. G. and Coleman, R. E. (1998). Cerebellar activity and disturbed time sense after THC. Brain Res., 797, 183–189CrossRef Google Scholar PubMed

Mechoulam, R. and Fride, E. (2001). A hunger for cannabinoids. Nature, 410, 763–765CrossRef Google Scholar PubMed

Mechoulam, R., Fride, E., Hanus, L.et al. (1997). Anandamide may mediate sleep induction. Nature, 389, 25–26CrossRef Google Scholar PubMed

Mendelson, J. H., Babor, T. F., Kuehnle, J. C.et al. (1976). Behavioral and biological aspects of marijuana use. Annal NY Acad. Sci., 282, 186–210CrossRef Google Scholar

Meng, I. D., Manning, B. H., Martin, W. J. and Fields, H. L. (1998). An analgesia circuit activated by cannabinoids. Nature, 395, 381–383CrossRef Google Scholar PubMed

Miller, L. L. and Branconnier, R. J. (1983). Cannabis: effects on memory and the cholinergic limbic system. Psychol. Bull., 93, 441–456CrossRef Google Scholar PubMed

Misner, D. L. and Sullivan, J. M. (1999). Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci., 19, 6795–6805CrossRef Google Scholar PubMed

Munro, S., Thomas, K. L. and Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61–65CrossRef Google Scholar PubMed

Nakamura-Palacios, E. M., Winsauer, P. J. and Moerschbaecher, J. M. (2000). Effects of the cannabinoid ligand SR141716A alone or in combination with delta-9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys. Behav. Pharmacol., 11, 377–386CrossRef Google Scholar PubMed

Ohno-Shosaku, T., Maejima, T. and Kano, M. (2001). Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron, 29, 729–738CrossRef Google Scholar PubMed

O'Leary, D. S., Block, R. I., Koeppel, J. A.et al. (2002). Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology, 26, 802–816CrossRef Google Scholar PubMed

Patel, S. and Hillard, C. J. (2001). Cannabinoid CB1 receptor agonists produce cerebellar dysfunction in mice. J. Pharmacol. Exp. Ther., 297, 629–637Google Scholar

Perio, A. A., Rinaldi-Carmona, M. M., Maruani, J. J.et al. (1996). Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist SR 141716A. Behav. Pharmacol., 7, 65–71Google Scholar PubMed

Pertwee, R. G. (1991). Tolerance to, and dependence on psychotropic cannabinoids. In The Biological Basis of Drug Tolerance, ed. J. Pratt, pp. 232–265. London: Academic Press

Pertwee, R. G. (1999). Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem., 6, 635–664Google Scholar PubMed

Pettit, D. A. D., Harrison, M. P., Olson, J. M., Spencer, R. F. and Cabral, G. A. (1998). Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J. Neurosci. Res., 51, 391–4023.0.CO;2-A>CrossRef Google Scholar PubMed

Pitler, T. A. and Alger, B. E. (1992). Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells. J. Neurosci., 12, 4122–4132CrossRef Google Scholar PubMed

Pitler, T. A. and Alger, B. E. (1994). Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron, 13, 1447–1455Google Scholar

Pontieri, F. E., Monnazzi, P., Scontrini, A., Buttarelli, F. R. and Patacchioli, F. R. (2001). Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. Eur. J. Pharmacol., 421, R1–R3CrossRef Google Scholar PubMed

Reibaud, M., Obinu, M. C., Ledent, C.et al. (1999). Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur. J. Pharmacol., 379, 1–2CrossRef Google Scholar PubMed

Rinaldi-Carmona, M., Barth, F., Heaulme, M.et al. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240–244CrossRef Google Scholar PubMed

Rodríguez de Fonseca, F., Rocio, M., Carrera, A.et al. (1997). Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science, 276, 2050–2054CrossRef Google Scholar PubMed

Rodríguez de Fonseca, F., Del Arco, I., Martín-Calderón, J. L., Gorriti, M. A. and Navarro, M. (1998). Role of the endogenous cannabinoid system in the regulation of motor activity. Neurobiol. Dis., 5, 483–501CrossRef Google Scholar PubMed

Roth, S. (1978). Stereoselective presynaptic inhibitory effect of delta-9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea pig. Can. J. Physiol. Pharmacol., 56, 968–975CrossRef Google Scholar

Rubino, T., Patrini, G., Massi, P.et al. (1998). Cannabinoid-precipitated withdrawal: a time course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J. Pharmacol. Exp. Ther., 285, 813–819Google Scholar PubMed

Santucci, V., Storme, J. J., Soubrie, P. and Fur, G. (1996). Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci., 58, 103–110CrossRef Google Scholar PubMed

Sañudo-Peña, M. C., Tsou, K. and Walker, J. M. (2000). Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci., 65, 703–713CrossRef Google Scholar

Schlicker, E. and Kathmann, M. (2001). Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci., 22, 565–572CrossRef Google Scholar PubMed

Shen, M., Piser, T. M., Seybold, V. S. and Thayer, S. A. (1996). Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci., 16, 4322–4334CrossRef Google Scholar PubMed

Smith, F. L., Cichewicz, D., Martin, Z. L. and Welch, S. P. (1998). The enhancement of morphine antinociception in mice by delta-9-tetrahydrocannabinol. Pharmacol. Biochem. Behav., 60, 559–566CrossRef Google Scholar

Solowij, N. (1998). Cannabis and Cognitive Functioning. Cambridge: Cambridge University Press

Stiglick, A. and Kalant, H. (1985). Residual effects of chronic cannabis treatment on behaviour in mature rats. Psychopharmacology, 85, 436–439CrossRef Google Scholar PubMed

Swift, W., Hall, W. and Teesson, M. (2001). Cannabis use and dependence among Australian adults: results from the National Survey of Mental Health and Wellbeing. Addiction, 96, 737–748CrossRef Google Scholar PubMed

Szabo, B., Siemes, S. and Wallmichrath, I. (2002). Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur. J. Neurosci., 15, 2057–2061CrossRef Google Scholar PubMed

Tanda, G., Pontieri, F. E. and Di Chiara, G. (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common µ1 opioid receptor mechanism. Science, 276, 2048–2050CrossRef Google Scholar PubMed

Tanda, G., Munzar, P. and Goldberg, S. R. (2000). Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nature Neurosci., 3, 1073–1074CrossRef Google Scholar PubMed

Terranova, J. P., Michaud, J. C., Fur, G.et al. (1995). Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55 212–2; reversal by SR141 716-A, a selective antagonist of CB1 cannabinoid receptors. Naunyn Schmiedbergs Arch. Pharmacol., 352, 576–579CrossRef Google Scholar

Terranova, J. P., Stomre, J. J., Lafon, N.et al. (1996). Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist SR141716A. Psychopharmacology, 126, 165–172CrossRef Google Scholar

Valverde, O., Maldonado, R., Valjent, E., Zimmer, A. M. and Zimmer, A. (2000). Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice. J. Neurosci., 15, 9284–9289CrossRef Google Scholar

Valverde, O., Noble, F.et al. (2001). Δ9-Tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur. J. Neurosci., 13, 1816–1824CrossRef Google Scholar PubMed

Varma, N., Calrson, G. C., Ledent, C. and Alger, B. E. (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J. Neurosci., 21, RC188–RC193CrossRef Google Scholar PubMed

Welch, S. P. and Stevens, D. L. (1992). Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J. Pharmacol. Exp. Ther., 262, 10–18Google Scholar PubMed

Williams, C. M. and Kirkham, T. C. (1999). Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology, 143, 315–317CrossRef Google Scholar PubMed

Wilson, R. I. and Nicoll, R. A. (2001). Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature, 410, 588–592CrossRef Google Scholar PubMed

Yamaguchi, T., Hagiwara, Y., Tanaka, H.et al. (2001). Endogenous cannabinoid 2-arachidonylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice. Brain Res., 909, 121–126CrossRef Google Scholar PubMed

Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. and Bonner, T. I. (1999). Increased mortality, hypoactivity and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl Acad. Sci. USA, 96, 5780–5785CrossRef Google Scholar PubMed